David S. Bateshansky, PharmD, BCOP

Articles by David S. Bateshansky, PharmD, BCOP

From Infusion Center Operations to Rounds: The Oncology Pharmacist’s Role at USC Norris Comprehensive Cancer Center

ByAlana Hippensteele, Lead Editor,David S. Bateshansky, PharmD, BCOP

March 16th 2025

David S. Bateshansky, PharmD, BCOP, discusses his role as an oncology pharmacist at USC Norris Comprehensive Cancer Center, noting the evolving recognition of pharmacists' contributions on cancer care teams.

Immunotherapy -- Image credit: LASZLO | stock.adobe.com

Impact of PD-1 and PD-L1 Expression on Overall Survival in Patients With NSCLC and Melanoma

ByAmin Zakkour Khudari, PharmD Candidate,Tammy Harutunyan, PharmD Candidate,Mohamad Zakour Khadari, MPharm,Rami Madani, MD Candidate,David S. Bateshansky, PharmD, BCOP,Amir Ali, PharmD, BCOP

August 14th 2024

Pharmacists play a vital role in therapy selection.

David S. Bateshansky, PharmD, BCOP

Articles by David S. Bateshansky, PharmD, BCOP

From Infusion Center Operations to Rounds: The Oncology Pharmacist’s Role at USC Norris Comprehensive Cancer Center

Impact of PD-1 and PD-L1 Expression on Overall Survival in Patients With NSCLC and Melanoma

Latest Updated Articles

Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights

FDA Approves Imlunestrant Tablets for ER+, HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer

IMWG Consensus Risk Criteria Predicts Survival in Daratumumab Quadruplet Therapy

Linvoseltamab Monotherapy Elicits Promising ORR, MRD-Negativity in NDMM

How Pharmacists Support CDK4/6 Inhibitor Management and Patient Care

Post-Marketing Surveillance Study Affirms Safety of Pneumococcal Vaccines